AtaiBeckley ATAI
NASDAQ ATAI
$7.40 +0.06 (+0.82%)
As of: Sep 4, 2026 · 3:16 PM EDT

AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026)

AtaiBeckley (ATAI) posted Net Cash Flow of -$31.1 million for Q3 2025, down 1001.36% sequentially from $3.4 million in Q2 2025, and down 398.95% YoY from $10.4 million in Q3 2024.

Analysis

AtaiBeckley (ATAI) Net Cash Flow (2020 - 2026) Analysis & Trends

AtaiBeckley's Net Cash Flow history runs 2 years deep, the most recent figure standing at -$41.9 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 236.33% year-over-year to -$41.9 million; the TTM figure through Mar 2026 stood at -$11.2 million (changed N/A YoY), while the FY2025 annual figure was $57.7 million, up 422.39% from the prior year.
  • Net Cash Flow slipped to -$31.1 million in Q3 2025 per ATAI's latest filing, from $3.4 million in the prior quarter.
  • The five-year high for Net Cash Flow was $30.8 million in Q1 2025, with the low at -$41.9 million in Q1 2026.
  • A 5-year average of -$3.5 million and a median of -$11.1 million in 2024 frame the typical range for Net Cash Flow.
  • The sharpest annual moves came in 2022 and 2025: Net Cash Flow sank 987.68% in 2022, then soared 763.91% in 2025.
  • Over 5 years, Net Cash Flow stood at -$67.4 million in 2021, then jumped by 172.12% to $48.6 million in 2022, then plunged by 164.26% to -$31.2 million in 2023, then surged by 43.73% to -$17.6 million in 2024, then tumbled by 76.72% to -$31.1 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$31.1 million, $3.4 million, and $30.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 374.50 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.43 Bn 27.59 Bn - 225.59 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.14 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn - -31.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.95 Mn
Mar 31, 2026 -41.92 Mn
Sep 30, 2025 -31.07 Mn
Jun 30, 2025 3.45 Mn
Jun 30, 2025 3.45 Mn
Mar 31, 2025 30.75 Mn
Mar 31, 2025 30.75 Mn
Dec 31, 2024 -17.58 Mn
Sep 30, 2024 10.39 Mn
Jun 30, 2024 399,000.00
Mar 31, 2024 -11.10 Mn
Dec 31, 2023 -31.25 Mn
Sep 30, 2023 -64.92 Mn
Jun 30, 2023 -44.72 Mn
Mar 31, 2023 -4.89 Mn
Dec 31, 2022 48.63 Mn
Sep 30, 2022 57.79 Mn
Jun 30, 2022 -38.35 Mn
Mar 31, 2022 -238.59 Mn
Dec 31, 2021 -67.42 Mn